Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effects of Metformin Drug in Diabetic Patients Suffering From Concomitant Infection With Covid-19; a Review Study Publisher



Shokoufamanesh A1 ; Nasri H2 ; Khosravifarsani M3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Public Health, Torbatjam Faculty of Medical Sciences, Torbat Jam, Iran
  2. 2. Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Cancer Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran

Source: Journal of Isfahan Medical School Published:2023


Abstract

Background: Diabetes is one of the most common co-morbidities and is associated with worse results in patients with coronavirus disease 2019 (COVID-19). The results showed that mortality was reduced among diabetics taking metformin compared with those not taking metformin. Therefore, the present study was conducted with the aim of providing reliable and up-to-date evidence about the effects of metformin drug in diabetic patients suffering from concomitant infection with COVID-19. Methods: In this review, we searched PubMed, Embase, Cochrane and Google Scholar databases starting in December 2019 to find studies. We carried out a systematic search of English texts using the keywords metformin or biguanides and coronavirus disease 2019 or COVID-19. After reviewing the titles, summaries and complete texts, 28 studies were eventually included in the study. Findings: The review found that most studies showed reduced mortality among metformin users compared to non-users among diabetics with COVID-19. In addition, the results indicate that metformin may inhibit viruses by increasing insulin susceptibility. However, some studies do not support the impact of metformin on mortality reduction. Conclusion: Results from this study show that metformin use in diabetic patients with COVID-19 is associated with decreased mortality. Of course, randomized controlled trials are necessary to confirm this outcome. © 2023 Isfahan University of Medical Sciences(IUMS). All rights reserved.
Other Related Docs
12. Drug Use Evaluation of Diabetes Mellitus in Non-Hospitalized Patients, International Journal of Pharmacy and Pharmaceutical Sciences (2016)
14. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
20. Covid-19 Management in the Emergency Ward, Journal of Research in Medical Sciences (2021)
25. Renoprotective Effects of Metformin, DARU, Journal of Pharmaceutical Sciences (2013)
28. Novel Drug Design for Treatment of Covid-19: A Systematic Review of Preclinical Studies, Canadian Journal of Infectious Diseases and Medical Microbiology (2022)
33. Metformin Induced Acute Kidney Injury; a Systematic Review, Journal of Nephropharmacology (2021)
36. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
37. Metformin and Renal Protection, Journal of Isfahan Medical School (2014)